Abstract
Transforming growth factors (TGFs) were originally defined by their biological effects on fibroblastic cells (for review see Goustin et al. 1986). These effects included induction of morphological transformation in monolayer culture and Stimulation of colony formation in soft agar. While the early studies with TGFα were somewhat misleading with respect to the function of these factors, they did lead to the purification and cloning of two important growth-regulatory molecules, TGFα and TGFβ. Interestingly, one of these factors (TGFα) is a potent mitogen for a wide variety of cell types, while the other (TGFβ) is the most potent growth-inhibitory Polypeptide known for most cell types (Goustin et al. 1986).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anzano MA, Roberts AB, Smith JM, Sporn MB, DeLarco JE (1983) Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type-alpha and type-beta transforming growth factors. Proc Natl Acad Sci USA 80: 6264–6268
Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB (1983) Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 258:7155–7160
Cate RL, Mattaliano RJ, Hession C, Tizard R, Farber NM, Cheung A, Ninfa EG, Frey AZ, Gash DJ, Chow EP, Fisher A, Bertonis JM, Torres G, Wallner BP, Ramachandran KL, Ragin RC, Managanaro TF, MacLaughlin DT, Donahoe PK (1986) Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cells 45: 685–698
Cheifetz S, Weatherbee JA, Tsang ML-S, Anderson JK, Mole JE, Lucas R, Massague J (1987) The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors. Cells 48: 409–415
Childs CB, Proper JA, Tucker RF, Moses HL (1982) Serum contains platelet-derived transforming growth factor. Proc Natl Acad Sci USA 79: 5312–5316
Coffey RJ, Derynck R, Wilcox JN, Bringman TS, Goustin S, Moses HL, Pittelkow MR (1987) Production and auto-induction of transforming growth factor-beta in human keratinocytes. Nature 328:817–820
Coughlin JP, Donahoe PK, Budzik GP, MacLaughlin DT (1987) Müllerian inhibiting substance blocks autophosphorylation of the EGF receptor by inhibiting tyrosine kinase. Mol Cell Endocrinol 49: 75–86
DeLarco JE, Todaro GJ (1978) Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci USA 75: 4001–4005
Derynck R (1986) Transforming growth factor-alpha: structure and biological activities. J Cell Biochem 32: 293–304
Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV (1985) Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 316:701–705
Derynck R, Jarrett JA, Chen EY, Goeddel DV (1986) The murine transforming growth factor-beta precursor. J Biol Chem 261:4377–4379
Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty JP, Angel P, Heath JK (1987) Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6: 1899–1904
Fernandez-Pol JA, Talked VD, Klos DJ, Hamilton PD (1987) Suppression of the EGF-dependent induction of c-mycproto-oncogene expression by transforming growth factor-beta in a human breast carcinoma cell line. Biochem Biophys Res Commun 144:1197–1205
Frolik CA, Wakefield LM, Smith DM, Sporn MB (1984) Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. J Biol Chem 259:10995–11000
Gentry LE, Webb NR, Lim GJ, Brunner AM, Ranchalis JE, Twardzik DR, Lioubin MN, Marquardt H, Purchio AF (1987) Type-1 transforming growth factor-beta: amplified expression and secretion of mature and precursor Polypeptides in Chinese hamster ovary cells. Mol Cell Biol 7: 4318–4327
Goustin AS, Leof EB, Shipley GD, Moses HL (1986) Perspective in cancer research: growth factors and cancer. Cancer Res 46:1015–1029
Holley RW, Armour R, Baldwin JH (1978) Density-dependent regulation of growth of BSC-1 cells in cell culture: growth inhibitors formed by the cells. Proc Natl Acad Sci USA 75: 1864–1866
Ignotz RA, Massague J (1986) Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337–4345
Ignotz RA, Endo R, Massague J (1987) Regulation of fibronectin and type-I collagen mRNA levels by transforming growth factor-beta. J Biol Chem 262:6443–6446
Keski-Oja J, Lyons RM, Moses HL (1987) Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta. Cancer Res 47: 6451–6458
Laiho M, Saksela O, Andreasen PA, Keski-Oja J (1986) Enhanced production and extracellular deposition of the endothelial-type Plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J Cell Biol 103:2403–2410
Lawrence DA, Pircher R, Kryceve-Martinerie C, Jullien P (1984) Normal embryo fibroblasts release trasforming growth factors in a latent form. J Cell Physiol 121: 184–188
Leof EB, Proper JA, Goustin AS, Shipley GD, DiCorleto E, Moses HL (1986) Induction of c-sismRNA and activity similar to platelet-derived growth factor by transforming growth factor-beta: a proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci USA 83:2453–2457
Like B, Massague J (1986) The antiproliferative effect of type beta transforming growth factor occurs at a level distal from receptors for growth-activating factors. J Biol Chem 261:13426–13429
Marquardt H, Hunkapiller MW, Hood LE, Todaro GJ (1984) Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science 223:1079–1082
Mason AJ, Hayflick JS, Ling N, Esch F, Ueno N, Ying Y, Guillemin R, Niall H, Seeburg PH (1985) Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta. Nature 318:659–663
Massague J (1985) Subunit structure of a high-affinity receptor for type-beta transforming growth factor. Evidence for a disulfide-linked glycosylated receptor complex. J Biol Chem 260: 7059–7066
Massague J (1987) The TGF-beta family of growth and differentiation factors. Cell 49:437–438
Massague J, Like B (1985) Cellular receptors for type-beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. J Biol Chem 260: 2636–2645
Masui T, Wakefield LM, Lechner JF, La Veck MA, Sporn B, Harris CC (1986) Type-beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc Natl Acad Sci USA 83: 2438–2442
Matrisian LM, Leroy P, Ruhlmann C, Gesnel M-C, Breathnach R (1986) Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts. Mol Cell Biol 6: 1679–1686
Moses HL, Leof EB (1986) Transforming growth factor-beta. In: Kahn P, Graf T (eds) Oncogene and Growth Control. Springer, Berlin, Heidelberg, New York, pp. 51–57
Moses HL, Branum EB, Proper JA, Robinson RA (1981) Transforming growth factor production by chemically transformed cells. Cancer Res 41: 2842–2848
Moses HL, Tucker RF, Leof EB, Coffey RJJ, Halper J, Shipley GD (1985) Type-beta transforming growth factor is a growth stimulator and a growth inhibitor. In: Feramisco J, Ozanne B, Stiles C (eds) Growth Factors and Transformation. Cancer Cells, vol 3. Cold Spring Harbor Press, Cold Spring Harbor, pp 65–71
Padgett RW, St Johnston RD, Gelbart WM (1987) A transcript from a Drosophila-patterngene predicts a protein homologous to the transforming growth factor-beta family. Nature 325:81–84
Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH (1987) Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor-beta. J Exp Med 165: 251–256
Raghow R, Postlethwaite AE, Keski-Oja J, Moses HL, Kang H (1987) Transforming growth factor-beta increases steady-state levels of type-I procollagen and fibronectin mRNA posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest 79:1285–1288
Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB (1981) New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissue. Proc Natl Acad Sci USA 78: 5339–5343
Roberts AB, Frolik CA, Anzano MA, Sporn MB (1983) Transforming growth factors from neoplastic and non-neoplastic tissues. Fed Proc 42: 2621–2626
Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl H, Fauci AS (1986) Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivoand stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83: 4167–4171
Shipley GD, Pittelkow MR, Wille JJJ, Scott RE, Moses L (1986) Reversible inhibition of normal human prokeratinocyte proliferation by type-beta transforming growth factor-growth inhibitor in serum-free medium. Cancer Res 46: 2068–2071
Sporn MB, Todaro GJ (1980) Autocrine secretion and malignant transformation of cells. N Engl JMed 303:878–880
Takehara K, LeRoy EC, Grotendorst GR (1987) TGF-beta inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression. Cell 49: 415–422
Todaro GJ, Fryling C, DeLarco JE (1980) Transforming growth factors produced by certain human tumor cells: Polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci USA 77: 5258–5262
Tucker RF, Branum EL, Shipley GD, Ryan RJ, Moses HL (1984a) Specific binding to cultured cells of 125I-labeled transforming growth factor type-beta from human platelets. Proc Natl Acad Sci USA 81: 6757–6761
Tucker RF, Shipley GD, Moses HL, Holley RW (1984b) Growth inhibitor from BSC-1 cells closely related to the platelet type-beta transforming growth factor. Science 226: 705–707
Twardzik DR, Ranchalis JE, Todaro GJ (1982) Mouse embryonic transforming growth factors related to those isolated from tumor cells. Cancer Res 42: 590–593
Wrann M, Bodmer S, de Martin R, Siepl C, Hofer-Warbinek R, Frei K, Hofer E, Fontana A (1987) T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta. EMBO J 6: 1633–1636
Ying S-Y, Becker A, Ling N, Ueno N, Guillemin R (1986) Inhibin and beta-type transforming growth factor (TGF-beta) have opposite modulating effects on the follicle-stimulating hormone (FSH)-induced aromatase activity of cultured rat granulosa cells. Biochem Biophys Res Commun 136:969–975
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Moses, H.L., Keski-Oja, J., Lyons, R.M., Sipes, N.J., Bascom, C.C., Coffey, R.J. (1989). Biological effects of transforming growth factors. In: MÜller, E.E., Cocchi, D., Locatelli, V. (eds) Advances in Growth Hormone and Growth Factor Research. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-11054-6_13
Download citation
DOI: https://doi.org/10.1007/978-3-662-11054-6_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-11056-0
Online ISBN: 978-3-662-11054-6
eBook Packages: Springer Book Archive